New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
04:55 EDTMDVN, MDVN, MDVN, MYGN, MYGN, MYGNAmerican Society of Clinical Oncology to hold symposium
ASCO 2014 Genitourinary (GU) Cancers Symposium is being held in San Francisco on January 30-February 1.
News For MDVN;MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:45 EDTMYGNMyriad Genetics presents tumor BRACAnalysis CDx study at ESMO
Subscribe for More Information
07:24 EDTMYGNStephens to hold an investor trip
Subscribe for More Information
September 24, 2014
09:59 EDTMDVNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:31 EDTMDVNMedivation downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Medivation to Neutral saying current share levels fairly value Xtandi's opportunities in prostate and breast cancer. Goldman raised its price target for shares to $110 from $90 and believes Medivation's fundamentals remain strong.
September 18, 2014
10:00 EDTMDVNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:47 EDTMDVNMedivation upgraded to Buy at Canaccord
As reported previously, Canaccord upgraded Medivation to Buy from Hold citing the pre-chemotherapy opportunity and meaningful incremental share gains of its Xtandi drug. Canaccord raised its price target on Medivation to $132 from $60.
06:13 EDTMDVNMedivation upgraded to Buy from Hold at Canaccord
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use